Tapewire

NYSE · USD

INSP

Inspire Medical Systems, Inc.

Export transactions ↓
Tapewire entity
1186
SEC CIK
0001609550
Parsed reports
589

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 18, 2022 Filed Apr 22, 2022 23:56 UTC
Herbert Timothy P.Director · CEO and President
Exercise / conversionCommon Stock 9,221 $1.47 $13,554.87
Disclosure

SEC source: 0001104659-22-049152 · tm2213386-1_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 14,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:47 UTC GrantCommon Stock 54 $254.08 $13,720.32
Disclosure

SEC source: 0001104659-22-045211 · tm2212578-5_4seq1.xml · nonDerivative · entry 1

Melenikiotou Georgia · CIK 0001817552 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:46 UTC GrantCommon Stock 59 $254.08 $14,990.72
Disclosure

SEC source: 0001104659-22-045210 · tm2212578-4_4seq1.xml · nonDerivative · entry 1

Tansey Casey M · CIK 0001474322 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,333

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:45 UTC GrantCommon Stock 51 $254.08 $12,958.08
Disclosure

SEC source: 0001104659-22-045207 · tm2212578-3_4seq1.xml · nonDerivative · entry 1

Broader Shelley G. · CIK 0001426843 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:44 UTC GrantCommon Stock 59 $254.08 $14,990.72
Disclosure

SEC source: 0001104659-22-045204 · tm2212578-2_4seq1.xml · nonDerivative · entry 1

Ellis Gary Lee · CIK 0001290170 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,034

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy.

Read SEC document
April 08, 2022 Filed Apr 13, 2022 00:44 UTC GrantCommon Stock 91 $254.08 $23,121.28
Disclosure

SEC source: 0001104659-22-045202 · tm2212578-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,801

F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
SaleCommon Stock 101 $255.99 $25,854.99
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 10

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,176

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
SaleCommon Stock 4,037 $257.90 $1,041,142.30
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 9

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,277

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.04 to $258.03. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
SaleCommon Stock 5,362 $258.50 $1,386,077.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 8

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,314

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $259.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
SaleCommon Stock 5,500 $259.46 $1,427,030.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 7

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,676

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.10 to $259.675. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2022 Filed Apr 8, 2022 20:15 UTC SaleCommon Stock 5,000 $270.00 $1,350,000.00
Disclosure

SEC source: 0001104659-22-044215 · tm2212208-1_4seq1.xml · nonDerivative · entry 2

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 76,130

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
April 01, 2022 Filed Apr 8, 2022 20:15 UTC SaleCommon Stock 5,000 $265.00 $1,325,000.00
Disclosure

SEC source: 0001104659-22-044215 · tm2212208-1_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 81,130

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:24 UTC SaleCommon Stock 98 $250.00 $24,500.00
Disclosure

SEC source: 0001104659-22-039631 · tm2210731-2_4seq1.xml · nonDerivative · entry 5

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 86,130

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:24 UTC SaleCommon Stock 5,000 $260.01 $1,300,050.00
Disclosure

SEC source: 0001104659-22-039631 · tm2210731-2_4seq1.xml · nonDerivative · entry 4

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 86,228

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.08. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:24 UTC SaleCommon Stock 5,000 $255.00 $1,275,000.00
Disclosure

SEC source: 0001104659-22-039631 · tm2210731-2_4seq1.xml · nonDerivative · entry 3

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 91,228

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.00 to $255.035. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 8,427 $252.37 $2,126,721.99
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 10

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 22,875

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.095 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 6,280 $251.41 $1,578,854.80
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 9

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 31,302

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 82,709 $250.27 $20,699,581.43
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 8

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 37,582

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.995. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 2,051 $252.20 $517,262.20
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 5

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,150

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.01 to $252.522. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 2,795 $251.46 $702,830.70
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 4

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,201

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.01 to $251.85. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 22,913 $250.36 $5,736,498.68
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 3

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,996

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.99. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 8,017 $252.39 $2,023,410.63
Disclosure

SEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 4

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,773

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.10 to $252.935. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023.

Read SEC document
March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 1,465 $251.92 $369,062.80
Disclosure

SEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 3

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 103,658

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.85 to $252.10. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Read SEC document
March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 13,619 $251.06 $3,419,186.14
Disclosure

SEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 105,123

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.78 to $251.77. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction based on reference to the total reported in the Reporting Person's Form 4/A related to transactions originally reported on March 21, 2022 and that was filed on March 13, 2023.

F7 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Read SEC document
March 29, 2022 Filed Mar 13, 2023 20:56 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 74,315 $250.20 $18,593,613.00
Disclosure

SEC source: 0001104659-23-031817 · tm239130-1_4aseq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 40,990

F1 · security: This Form 4 amends and restates the previously reported sale transactions made by the Margaret C. Herbert 2018 Family Irrevocable GST Trust that occurred on March 29, 2022 in order to re-allocate such sales between three different sellers that are considered beneficially owned by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Margaret C. Herbert 2018 Family Irrevocable GST Trust, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sales by such trust on March 29, 2022 by 23,101 shares, which is corrected herein.

F4 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 00:24 UTC SaleCommon Stock 2,323 $250.00 $580,750.00
Disclosure

SEC source: 0001104659-22-039631 · tm2210731-2_4seq1.xml · nonDerivative · entry 2

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 96,228

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 2,542 $250.00 $635,500.00
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 7

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 120,291

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 1,546 $250.00 $386,500.00
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,909

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.01. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 00:24 UTC SaleCommon Stock 2,579 $250.01 $644,775.79
Disclosure

SEC source: 0001104659-22-039631 · tm2210731-2_4seq1.xml · nonDerivative · entry 1

NELSON MARILYN C · CIK 0001199894 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 98,551

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.165. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 42 $250.00 $10,500.00
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 6

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By family trust

Disclosed balance after: 122,833

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F6 · ownership.nature: Shares held by the Margaret C. Herbert 2018 Family Irrevocable GST Trust.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 00:31 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 695 $250.00 $173,750.00
Disclosure

SEC source: 0001104659-22-039633 · tm2210731-1_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,455

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 21:43 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 36 $227.53 $8,191.08
Disclosure

SEC source: 0001104659-22-036197 · tm2210029-1_4seq1.xml · nonDerivative · entry 3

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,150

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.515 to $227.58. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 21:43 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 1,233 $226.13 $278,818.29
Disclosure

SEC source: 0001104659-22-036197 · tm2210029-1_4seq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,186

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.04 to $226.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 21:43 UTC
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 18,731 $225.35 $4,221,030.85
Disclosure

SEC source: 0001104659-22-036197 · tm2210029-1_4seq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,419

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.00 to $225.995. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 250 shares acquired under the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
March 17, 2022 Filed Mar 13, 2023 20:55 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 36 $227.53 $8,191.08
Disclosure

SEC source: 0001104659-23-031814 · tm239130-2_4aseq1.xml · nonDerivative · entry 4

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 118,742

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.515 to $227.58. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Read SEC document
March 17, 2022 Filed Mar 13, 2023 20:55 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 1,193 $226.13 $269,773.09
Disclosure

SEC source: 0001104659-23-031814 · tm239130-2_4aseq1.xml · nonDerivative · entry 3

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 118,778

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.04 to $226.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction based on the total reported in the Reporting Person's most recent Form 4, dated March 13, 2023.

F6 · ownership.nature: Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Read SEC document
March 17, 2022 Filed Mar 13, 2023 20:55 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 40 $226.04 $9,041.60
Disclosure

SEC source: 0001104659-23-031814 · tm239130-2_4aseq1.xml · nonDerivative · entry 2

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,790

F3 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Reporting Person, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sale of shares directly held by the Reporting Person on March 17, 2022 by 1,229 shares, which is corrected herein.

Read SEC document
March 17, 2022 Filed Mar 13, 2023 20:55 UTC Amendment
Herbert Timothy P.Director · CEO and President
SaleCommon Stock 18,731 $225.35 $4,221,030.85
Disclosure

SEC source: 0001104659-23-031814 · tm239130-2_4aseq1.xml · nonDerivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,790

F1 · security: This Form 4 amends and restates the previously reported sale transactions made by the Reporting Person that occurred on March 17, 2022 in order to reallocate such sales between the Reporting Person and a trust that is considered beneficially owned by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.00 to $225.995. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: The amount of securities listed in Column 5 reflects the total shares held following the transaction owned by the Reporting Person, by reference to the total reported in the Reporting Person's Form 4 filed on March 13, 2023. The total has increased from such Form 4 as a result of the prior overstatement of the sale of shares directly held by the Reporting Person on March 17, 2022 by 1,229 shares, which is corrected herein.

Read SEC document
February 18, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 6

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Son

Disclosed balance after: 1,125

Read SEC document
February 18, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 5

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Son

Disclosed balance after: 1,125

Read SEC document
February 18, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 4

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,176

Read SEC document
February 17, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 3

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Son

Disclosed balance after: 1,125

Read SEC document
February 17, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 125 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 2

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Daughter

Disclosed balance after: 1,125

Read SEC document
February 17, 2022 Filed Apr 5, 2022 23:41 UTC
Buchholz RichardChief Financial Officer
GiftCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-042917 · tm2211772-1_4seq1.xml · nonDerivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,426

F1 · balance_after: Includes 52 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan on December 31, 2021.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:33 UTC
Ban RandyChief Commercial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 5,924 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023827 · tm226817-5_4seq1.xml · derivative · entry 1

Ban Randy · CIK 0001737127 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924

Underlying: Common Stock · 5,924 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:34 UTC
Buchholz RichardChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 5,924 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023829 · tm226817-6_4seq1.xml · derivative · entry 1

Buchholz Richard · CIK 0001737133 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924

Underlying: Common Stock · 5,924 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:32 UTC
Phillips Bryan KSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 5,924 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023825 · tm226817-4_4seq1.xml · derivative · entry 1

Phillips Bryan K · CIK 0001412895 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924

Underlying: Common Stock · 5,924 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:31 UTC
Ebeling PhilipChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 5,924 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023821 · tm226817-2_4seq1.xml · derivative · entry 1

Ebeling Philip · CIK 0001662781 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924

Underlying: Common Stock · 5,924 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:32 UTC
Jandrich StevenVP Human Resources
GrantEmployee Stock Option (Right to Buy) · Derivative 5,924 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023824 · tm226817-3_4seq1.xml · derivative · entry 1

Jandrich Steven · CIK 0001737203 · VP Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,924

Underlying: Common Stock · 5,924 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:30 UTC
Herbert Timothy P.Director · CEO and President
GrantEmployee Stock Option (Right to Buy) · Derivative 17,773 $0.00 Strike: $227.53 $0.00
Disclosure

SEC source: 0001104659-22-023818 · tm226817-1_4seq1.xml · derivative · entry 1

Herbert Timothy P. · CIK 0001737136 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,773

Underlying: Common Stock · 17,773 shares

Expires 2032-02-11

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of Feruary 11, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.